https://www.selleckchem.com/pr....oducts/vps34-inhibit
No significant difference was found in the sigmoid D2cc dose goal. Conclusions In small volume tumors ( less then 30 cc), hybrid applicators may offer improved OAR sparing compared with conventional tandem and ring applicators, and may increase the proportion of patients meeting EMBRACE II OAR goals. Copyright © 2020 Termedia.Purpose To monitor the outcomes for intermediate-risk prostate cancer patients treated with biologically effective dose (BED) ≥ 200 Gy radiotherapy using low-dose-rate (LDR) brachytherapy. Material and me
Like
Comment
Share